VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review

Abstract

Congenital myasthenic syndrome-25 (CMS-25) is an autosomal recessive neuromuscular disorder caused by a homozygous mutation in VAMP1 gene. To date, only eight types of allelic variants in VAMP1 gene have been reported in 12 cases of CMS-25. Here, we report on an 8-year-old boy with motor developmental delay, axial hypotonia, myopathic face, muscle weakness, strabismus, ptosis, pectus carinatum, kyphoscoliosis, joint contractures, joint laxity, seizures, and recurrent nephrolithiasis. He also had feeding difficulties and recurrent aspiration pneumonia. Brain magnetic resonance imaging at 20 months of age showed left focal cerebellar hypoplasia. Genetic analysis revealed a homozygous missense variant of c.202C > T (p.Arg68Ter) in the VAMP1 gene. Treatment with oral pyridostigmine was started, which resulted in mild improvement in muscle strength. Salbutamol syrup was added a few months later, but no significant improvement was observed. This case report presents novel findings such as focal cerebellar hypoplasia and nephrolithiasis in VAMP1-related CMS-25. Consequently, this case report extends the clinical spectrum. Further studies are needed to expand the genotype–phenotype correlations in VAMP1-related CMS-25.

Keywords

congenital myasthenic syndromes - presynaptic - VAMP1 - cerebellar hypoplasia

Publication History

Received: 16 January 2024

Accepted: 19 February 2024

Article published online:
26 March 2024

• References

• 1 Palace J, Beeson D. The congenital myasthenic syndromes. J Neuroimmunol 2008; 201-202: 2-5
• 2 Ohno K, Ohkawara B, Shen XM, Selcen D, Engel AG. Clinical and pathologic features of congenital myasthenic syndromes caused by 35 genes-a comprehensive review. Int J Mol Sci 2023; 24 (04) 3730
• 3 Shen XM, Selcen D, Brengman J, Engel AG. Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability. Neurology 2014; 83 (24) 2247-2255
• 4 Shen XM, Scola RH, Lorenzoni PJ. et al. Novel synaptobrevin-1 mutation causes fatal congenital myasthenic syndrome. Ann Clin Transl Neurol 2017; 4 (02) 130-138
• 5 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 6 Polavarapu K, Vengalil S, Preethish-Kumar V. et al. Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes - a recognizable clinical phenotype. Eur J Paediatr Neurol 2021; 31: 54-60
• 7 Liu Y, Sugiura Y, Lin W. The role of synaptobrevin1/VAMP1 in Ca2+-triggered neurotransmitter release at the mouse neuromuscular junction. J Physiol 2011; 589 (Pt 7): 1603-1618
• 8 Al-Muhaizea MA, AlQuait L, AlRasheed A. et al. Pyrostigmine therapy in a patient with VAMP1-related congenital myasthenic syndrome. Neuromuscul Disord 2020; 30 (07) 611-615
• 9 Nair P, Sabbagh S, Mansour H. et al. Contribution of next generation sequencing in pediatric practice in Lebanon. A study on 213 cases. Mol Genet Genomic Med 2018; 6 (06) 1041-1052
• 10 Megarbane A, Bizzari S, Deepthi A. et al. A 20-year clinical and genetic neuromuscular cohort analysis in Lebanon: an international effort. J Neuromuscul Dis 2022; 9 (01) 193-210
• 11 Monies D, Abouelhoda M, AlSayed M. et al. The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes. Hum Genet 2017; 136 (08) 921-939
• 12 Salpietro V, Lin W, Delle Vedove A. et al; SYNAPS Study Group. Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome. Ann Neurol 2017; 81 (04) 597-603
• 13 Elferink LA, Trimble WS, Scheller RH. Two vesicle-associated membrane protein genes are differentially expressed in the rat central nervous system. J Biol Chem 1989; 264 (19) 11061-11064